| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.388 | 20.476 | 49.123 | 41.146 | 65.542 | 25.393 | 9.466 | - | - | - |
| Total Income - EUR | 33.404 | 20.476 | 53.413 | 41.191 | 65.491 | 25.393 | 9.466 | - | - | - |
| Total Expenses - EUR | 30.035 | 20.277 | 51.292 | 41.509 | 61.996 | 29.730 | 17.020 | - | - | - |
| Gross Profit/Loss - EUR | 3.369 | 199 | 2.121 | -319 | 3.495 | -4.337 | -7.554 | - | - | - |
| Net Profit/Loss - EUR | 2.830 | 156 | 1.711 | -902 | 2.840 | -5.069 | -7.838 | - | - | - |
| Employees | 2 | 1 | 1 | 1 | 1 | 0 | 0 | - | - | - |
Check the financial reports for the company - R - Esprofusion Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.442 | 5.867 | 129 | 0 | 0 | 0 | 0 | - | - | - |
| Current Assets | 3.047 | 7.094 | 18.350 | 35.916 | 53.123 | 46.948 | 36.432 | - | - | - |
| Inventories | 0 | 1.348 | 315 | 7.144 | 175 | 3 | 62 | - | - | - |
| Receivables | 2.414 | 5.132 | 6.923 | 9.654 | 17.626 | 22.480 | 22.912 | - | - | - |
| Cash | 634 | 613 | 11.112 | 19.117 | 35.322 | 24.464 | 13.457 | - | - | - |
| Shareholders Funds | 8.865 | 8.930 | 6.247 | 3.082 | 5.862 | 682 | -7.171 | - | - | - |
| Social Capital | 45 | 45 | 90 | 88 | 86 | 85 | 83 | - | - | - |
| Debts | 3.982 | 4.234 | 12.279 | 32.834 | 47.261 | 46.266 | 43.603 | - | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4644 - 4644" | |||||||||
| CAEN Financial Year |
4644
|
|||||||||
Comments - R - Esprofusion Srl